Research Careers Committee awards

Senior Cancer Research Fellowship

November 2025

Dissecting the molecular origins of ductular carcinomas in chronic tissue disease and regeneration

Dr Luke Boulter

University of Edinburgh

Explore the Senior Cancer Research Fellowship

Advanced Clinician Scientist Fellowship

This funding scheme is now closed.

May 2026

Deciphering vascular growth and endothelial-mediated immunosuppression in human gliomas

Dr Thomas Wälchli

University College London

November 2025

Cancer-selective CAR-T therapies for T cell malignancies

Dr Paul Maciocia

University College London

Career Development Fellowship

May 2026

Harnessing synthetic lethality for early therapeutic interception in hereditary and sporadic MMR-deficient cancers

Dr Gabriele Picco

University of Cambridge

Dissecting the interplay between T cell immunity and senescence in liver cancer

Dr Riccardo Mezzadra

Cancer Research UK Scotland Institute

November 2025

Investigating the role of KRAS wildtype epithelial cells in pancreatic cancer initiation and progression

Dr Beatriz Salvador Barbero

Queen Mary University of London

Exploiting antibody-dependent cellular phagocytosis to treat hepatocellular carcinoma

Dr Felipe Galvez-Cancino

University of Oxford

Quantifying differentiation dynamics and dissecting their molecular regulation in myelodysplastic syndrome and acute myeloid leukemia

Dr Verena Korber

University of Oxford

Harnessing post-operative blood-brain barrier permeability for targeted nano therapies against aggressive brain tumours

Dr Thomas Kisby

The University of Manchester

Explore the Career Development Fellowship

Career Establishment Award

November 2025

Targeting cancer-associated fibroblast responses to metabolic stress to overcome the immunosuppressed tumour niche in hepatocellular carcinoma

Dr Jack Leslie

Newcastle University

Explore the Career Establishment Award

Clinician Scientist Fellowship

May 2026

Systematic gene editing to target synthetic lethal interactions in uveal melanoma

Dr Jenny Pui Ying Chan

Wellcome Sanger Institute

Targeted radionuclide therapy to mitigate spatiotemporal heterogeneity and overcome treatment resistance in oesophagogastric adenocarcinoma

Dr Christopher Jones

University of Cambridge

Explore the Clinician Scientist Fellowship

Pre-doctoral Research Bursary

May 2026

Comparative transcriptomic profiling of pre-metastatic and primary metastatic phaeochromocytomas and paragangliomas (PPGLs) to identify predictive molecular markers of metastasis

Dr Ernest Chi Hei Lee

King's College London

(co-funded by Cancer Research UK and the Pathological Society)

A histology-based framework for assessing tumour-brain network integration in paediatric high-grade glioma

Dr Melanie Jensen

University College London Great Ormond Street Institute of Child Health

(co-funded by Cancer Research UK and the Pathological Society)

Evaluating the determinants of poor response to immune checkpoint inhibitor therapy in advanced hepatocellular carcinoma (HCC)

Dr Mzamo Mbelle

King's College London

November 2025

Integration of epidemiology and spatial transcriptomics to study reproductive factors in renal cell carcinoma

Dr Katherine Wong

University of Oxford

(co-funded by Cancer Research UK and the Pathological Society)

PROSPECT-PLEURA: biomarker discovery to refine diagnosis and prognosis in histologically indeterminate pleural effusions

Dr Oliver Mann

Lancaster University

Incidence, survival and risk factors for early-onset oesophageal adenocarcinoma in England: a population-based cohort study using linked NHS data

Dr Mie Thu Ko

University of East Anglia

Exploring the B cell immune landscape in patients with cholangiocarcinoma receiving immunotherapy

Dr Richard Phillips

University of Birmingham

Explore the Pre-doctoral Research Bursary

Postdoctoral Research Bursary

This funding scheme is now closed.

November 2025

Targeting therapeutics to the leading edge of glioblastoma to prevent post-operative recurrence

Dr Mitchell Foster

University of Edinburgh

Replication stress relief mechanisms as dependencies in acute myeloid leukaemia

Dr Tumas Beinortas

University of Cambridge

Spatially resolved transcriptomic characterisation of adaptive cellular responses to neoadjuvant Encorafenib and Cetuximab in BRAF mutant colon cancer

Dr Mark White

Cancer Research UK Scotland Institute

Clinical Trial Fellowship

This funding scheme is now closed.

November 2025

Advancing cancer precision prevention and early detection through trials in primary care

Dr Laura Heath

University of Oxford

Developing a future clinical trial oncologist in novel and precision therapies

Dr Amani Chowdhury

University College London

Bridge to Academic Leadership

May 2025

Identifying novel targets for proximal colon cancer prevention and early detection

Dr Rhea Harewood

Imperial College London

Advanced causal modelling to improve understanding of late effects of radiotherapy in children and young adults

Dr Angela Davey

The University of Manchester

Gaining traction in glioblastoma therapy: targetable mechanisms of force generation

Dr Alexander Loftus

University of Edinburgh

Refining HER2 diagnostics for an ultra-sensitive, objective assessment to guide therapy, inform resistance and monitor dynamic changes

Dr Rebecca Allsopp

University of Leicester

Targeting translation quality control machinery to enhance the efficiency of genotoxic drugs in colon cancer

Dr Susanta Chatterjee

Queen's University Belfast

Investigating cancer induced haematopoietic dysfunction: impact, mechanism and therapeutic potential

Dr Christopher Mapperley

Institute of Cancer Research

Explore the Bridge to Academic Leadership programme